4108 Stock Overview
Researches and develops, manufactures, and sells pharmaceutical drugs, cosmetics, Class B medicines, and dietary supplements in Taiwan. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
PhytoHealth Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$16.20 |
| 52 Week High | NT$24.00 |
| 52 Week Low | NT$15.75 |
| Beta | 1.01 |
| 11 Month Change | -7.95% |
| 3 Month Change | -12.43% |
| 1 Year Change | -31.36% |
| 33 Year Change | -32.50% |
| 5 Year Change | -14.74% |
| Change since IPO | -72.07% |
Recent News & Updates
Shareholder Returns
| 4108 | TW Pharmaceuticals | TW Market | |
|---|---|---|---|
| 7D | 1.9% | 0.6% | -0.8% |
| 1Y | -31.4% | 9.2% | 29.0% |
Return vs Industry: 4108 underperformed the TW Pharmaceuticals industry which returned 9.2% over the past year.
Return vs Market: 4108 underperformed the TW Market which returned 29% over the past year.
Price Volatility
| 4108 volatility | |
|---|---|
| 4108 Average Weekly Movement | 2.6% |
| Pharmaceuticals Industry Average Movement | 3.8% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in TW Market | 8.0% |
| 10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 4108 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 4108's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | n/a | I-Lin Lee | www.phytohealth.com.tw |
PhytoHealth Corporation researches and develops, manufactures, and sells pharmaceutical drugs, cosmetics, Class B medicines, and dietary supplements in Taiwan. The company operates in three segments: Pharmaceutical Drugs and Dietary Supplement, Medical Diagnostic Products, and Precision Medical Equipment. The Pharmaceutical Drugs and Dietary Supplement segment manufactures and sells Chinese medicine and new pharmaceutical products.
PhytoHealth Corporation Fundamentals Summary
| 4108 fundamental statistics | |
|---|---|
| Market cap | NT$3.22b |
| Earnings (TTM) | -NT$86.82m |
| Revenue (TTM) | NT$163.13m |
19.7x
P/S Ratio-37.1x
P/E RatioIs 4108 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4108 income statement (TTM) | |
|---|---|
| Revenue | NT$163.13m |
| Cost of Revenue | NT$98.02m |
| Gross Profit | NT$65.12m |
| Other Expenses | NT$151.93m |
| Earnings | -NT$86.82m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.44 |
| Gross Margin | 39.92% |
| Net Profit Margin | -53.22% |
| Debt/Equity Ratio | 0% |
How did 4108 perform over the long term?
See historical performance and comparison